PharmiWeb.com - Global Pharma News & Resources

General - Press Releases

Date Title Company
03-Feb-2022 TXOG Announces Texas’ First 20 mg Medical Cannabis Gummy Businesswire
03-Feb-2022 Nexien BioPharma Engages Dr. Benedikt Schoser as Advisor Newswire
03-Feb-2022 Global Sports Nutrition Market (2022 to 2027) - Industry Trends, Share, Size, Growth, Opportunity and Forecasts - ResearchAndMarkets.com Businesswire
03-Feb-2022 In-Vitro Toxicity Testing Technologies and Global Markets Report 2022 - ResearchAndMarkets.com Businesswire
03-Feb-2022 Wearable Medical Devices Technologies and Global Markets Report 2021-2026 - ResearchAndMarkets.com Businesswire
03-Feb-2022 Cyclo Therapeutics Announces Formation of Global Steering Committee Comprised of Leading Experts to Advise on the Global Phase 3 Clinical Development Program for Trappsol® Cyclo™ in Niemann-Pick Disease Type C Businesswire
03-Feb-2022 Kiromic BioPharma Appoints Frank Tirelli and Dr. Karen Reeves to Company’s Board of Directors Businesswire
03-Feb-2022 Biosero Joins Genedata Ready-to-Run Program to Streamline Lab Automation and Data Analysis Businesswire
03-Feb-2022 Ermium Therapeutics Announces the Formation of a Scientific Advisory Board Businesswire
03-Feb-2022 Worldwide Clinical Trials and Ledger Run Partner to Optimize Clinical Research Business Operations Businesswire
03-Feb-2022 BioCardia Receives FDA Breakthrough Device Designation for CardiAMP Cell Therapy System for Heart Failure Businesswire
03-Feb-2022 Curie Therapeutics Appoints Kapil Dhingra, MBBS, to Board of Directors Businesswire
03-Feb-2022 ADCETRIS® Combination Significantly Improves Overall Survival in Newly Diagnosed Patients with Advanced Hodgkin Lymphoma Businesswire
03-Feb-2022 Charles River Laboratories Announces Wind Contract with Repsol for European Operations Businesswire
03-Feb-2022 Redwire Announces Preliminary Full Year 2021 Revenue and Backlog; Provides Update on Q3 2021 10-Q Filing Businesswire
03-Feb-2022 Surmodics Reports First Quarter Fiscal 2022 Results Businesswire
03-Feb-2022 JCR Pharmaceuticals Receives the WORLDSymposium™ New Treatment Award for IZCARGO® (Pabinafusp Alfa) Businesswire
03-Feb-2022 Marinus Pharmaceuticals Completes In Vivo M2 Metabolite Study and Provides European Regulatory Update Businesswire
03-Feb-2022 KalVista Pharmaceuticals to Present at SVB Leerink Global Healthcare Conference Businesswire
03-Feb-2022 PENTAX Medical Europe launches premium solution PlasmaTYPHOON+ PENTAX Medical Europe